Özet:

Renal transplantation is a preferred treatment option due to its low long-term mortality and improved quality of life. However, the complications that develop after transplantation affect the survival of the transplant kidney and the patient. Transplant renal artery stenosis (TRAS) is a vascular complication that occurs after a renal transplant. It affects 1 to 23 percent of patients. Although the refractor often causes hypertension, it can also lead to greft loss. It can be seen in the second day after a renal transplant, as it can be seen years after the operation. While peripheral angiography (Digital subtraction angiography) is the golden standard for the TRAS diagnosis, Doppler USG has become the primary imaging method because it is portable, cheap and non-invasive. There are surgical and endoluminal options. In this article, a 16-year-old girl who developed renal arterial stenosis in the fourth month after kidney transplant and was to have been monitored by the second year after transplant by the application of percutaneous transluminal ballon angioplasty, without the need for antihypertensive treatment and continuing the greft function whileined.

Anahtar Kelimeler:

Özet:

Renal transplantation is a preferred treatment option because of its low long-term mortality and increased quality of life. However, complications after transplantation affect graft and patient survival. Transplant Renal Artery Stenosis (TRAS) is the most common vascular complication following renal transplantation affecting 1-23% of patients. Although it usually causes refractory hypertension, it can also cause graft loss. Although Peripheral Angiography (Digital subtraction angiography) is the gold standard for the diagnosis of TRAS, Doppler USG has become a primary imaging method because it is portable, inexpensive and noninvasive. There are surgical and endoluminal options in the treatment. In this report, a 16-year-old girl who had renal artery stenosis at the 4th month after renal transplantation and underwent percutaneous transluminal balloon angioplasty was reported. She is now in her second year of transplantation without any need for antihypertensive treatment and with preserved graft function.